Substituted azole derivatives as therapeutic agents

Details for Australian Patent Application No. 2004210711 (hide)

Owner TransTech Pharma, Inc.

Inventors Yarragunta, Ravindra R.; Mjalli, Adnan M.M.; Subramanian, Govindan; Arimilli, Murty N.; Andrews, Robert C.; Xie, Rongyuan; Quada, Jr. James C.; Polisetti, Dharma R.

Agent Pizzeys

Pub. Number AU-B-2004210711

PCT Pub. Number WO2004/071447

Priority 60/446,977 12.02.03 US

Filing date 12 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 8 July 2010

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/071447 Priority application(s): WO2004/071447

23 November 2006 Change of Name(s) of Applicant(s), Section 104

  Transtech Pharma Inc. The name of the applicant has been changed to TransTech Pharma, Inc.

8 July 2010 Application Accepted

  Published as AU-B-2004210711

4 November 2010 Standard Patent Sealed

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210713-A fluid dispensing accessory

2004210710-Articular disc prosthesis for lateral insertion